AH
Therapeutic Areas
Bavarian Nordic Pipeline
| Drug | Indication | Phase |
|---|---|---|
| MVA-BN RSV | Respiratory Syncytial Virus (RSV) prevention | Phase 3 |
| MVA-BN HIV | Human Immunodeficiency Virus (HIV) prevention/therapy | Phase 2 |
| Chikungunya Vaccine (CHIKV) | Chikungunya virus prevention | Phase 3 |
| MVA-BN Filo | Ebola Virus Disease (Sudan and Marburg strains) prevention | Phase 2 |
| MVA-BN MPox/Smallpox | Mpox and Smallpox prevention in children | Regulatory Submission |